Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Table 1

Basal characteristics of patients infected with COVID-19.

	NDM ()	T2D ()	value
Age distribution
25-49, (%)	6 (19.6%)	5 (13.5%)	0.592
50-64, (%)	10 (30.3%)	15 (40.5%)	0.372
≥65, (%)	17 (51.5%)	17 (45.9%)	0.641
Age (years)			0.690
Sex
Female, (%)	15 (45.5%)	18 (48.6%)	0.699
Severity classification
Mild type, (%)	16 (48.5%)	7 (18.9%)	—
Moderate type, (%)	13 (39.4%)	20 (54.1)	—
Severe cases, (%)	4 (12.1%)	9 (24.3%)	—
Critically ill type, (%)	0 (0.0%)	1 (2.7%)	—
Comorbidities at admission
Mixed bacterial infection, (%)	4 (12.1%)	12 (32.3%)
Cardiovascular diseases, (%)	14 (42.4%)	21 (77.8%)	0.231
Digestive system disease, (%)	2 (6.1%)	3 (8.1%)	0.895
Respiratory system diseases, (%)	2 (6.1%)	3 (8.1%)	0.895
Chronic kidney disease, (%)	2 (6.1%)	5 (18.5%)	0.521
Chronic liver disease, (%)	1 (3.0%)	1 (2.7%)	0.628
HIV infection, (%)	0 (0.0%)	0 (0.0%)	1.000
Septic shock, (%)	0 (0.0%)	0 (0.0%)	1.000